Alternative complement pathway and factor B activities in rats with altered blood levels of thyroid hormone
AUTOR(ES)
Bitencourt, C.S., Duarte, C.G., Azzolini, A.E.C.S., Assis-Pandochi, A.I.
FONTE
Brazilian Journal of Medical and Biological Research
DATA DE PUBLICAÇÃO
2012-03
RESUMO
Evaluating the activity of the complement system under conditions of altered thyroid hormone levels might help elucidate the role of complement in triggering autoimmune processes. Here, we investigated alternative pathway (AP) activity in male Wistar rats (180 ± 10 g) after altering their thyroid hormone levels by treatment with triiodothyronine (T3), propylthiouracil (PTU) or thyroidectomy. T3 and thyroxine (T4) levels were determined by chemiluminescence assays. Hemolytic assays were performed to evaluate the lytic activity of the AP. Factor B activity was evaluated using factor B-deficient serum. An anti-human factor B antibody was used to measure factor B levels in serum by radial immunodiffusion. T3 measurements in thyroidectomized animals or animals treated with PTU demonstrated a significant reduction in hormone levels compared to control. The results showed a reduction in AP lytic activity in rats treated with increasing amounts of T3 (1, 10, or 50 µg). Factor B activity was also decreased in the sera of hyperthyroid rats treated with 1 to 50 µg T3. Additionally, treating rats with 25 µg T3 significantly increased factor B levels in their sera (P < 0.01). In contrast, increased factor B concentration and activity (32%) were observed in hypothyroid rats. We conclude that alterations in thyroid hormone levels affect the activity of the AP and factor B, which may in turn affect the roles of AP and factor B in antibody production.
Documentos Relacionados
- Abrogation of the alternative complement pathway by targeted deletion of murine factor B
- Evasion of alternative complement pathway by Trypanosoma cruzi results from inefficient binding of factor B.
- Novel pathway for thyroid hormone receptor action through interaction with jun and fos oncogene activities.
- Activation of the alternative pathway of complement by mycobacteria and cord factor.
- Expression of the thyroid hormone receptor gene, erbAalpha, in B lymphocytes: alternative mRNA processing is independent of differentiation but correlates with antisense RNA levels.